The hallucinogenic compound psilocybin is undergoing a renaissance-not as a recreational drug but as a potential treatment for mental health conditions. We follow the journey of one participant of a scientific study into the psychedelic drug's effect on depression.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Fler avsnitt av Bold Names
Visa alla avsnitt av Bold NamesBold Names med The Wall Street Journal finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
